The importance of this finding is that the loss of ER-α in breast cancer patients is indicative of a poor prognosis,10, 13 and this reduced expression or absence of ER-α caused by ZEB1 may have implications for ER-α-negative and/or antiestrogen-resistant breast cancers. The gene discussed is ZEB1; the disease is breast carcinoma.